After following your MNTA posts, I've decided to start building up my shares in MNTA. I've got my fingers crossed that theirs is the only generic Lovenox approved. I believe MNTA has some of the smartest guys in the industry on their senior management team. All Ivy League schooled.
Not expecting VNDA-like spike, even under best case scenario as Market Cap is already close to 400 million. Not sure how under-the radar MNTA is, although volume of shares traded is relatively low.
Added more MNTA @8.59-8.66. I’m now pretty sure they are seeking to raise money; however, I don’t think the terms will be bad for the company and the share price may even rise on the announcement as happened with the previous financing in December.
Market Data 
Markets 
AI
